Trial intelligence / Profile preview

Efficacy of Adding Clobetasol Foam to Etanercept in Plaque Psoriasis

NCT01235442Phase 3Completed

Sponsor
Amgen
Start
Sep 2010
Primary completion
Oct 2011
Modality
Fc-Fusion Proteins
01

Overview

A Phase 3 trial of etanercept in plaque psoriasis, sponsored by Amgen. Started Sep 2010; status: completed.

02

Drugs

etanercept
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01235442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01235442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call